Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2017 Nov 03
Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn's disease.
Related Questions
How should IVIG and either biologic injections or infusions be spaced?
New answer by at Emory University (November 30, 2023)
I definitely agree with Dr. @Matilda Nicholas' concerns.
For what it’s worth, I use a lot of IVIG in combination with monoclonal medications in my myositis clinic,...